ID   HIPA_ECOLI              Reviewed;         440 AA.
AC   P23874; P76139; P76880; P77507;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2003, sequence version 2.
DT   22-JUL-2015, entry version 119.
DE   RecName: Full=Serine/threonine-protein kinase HipA;
DE            Short=Ser/Thr-protein kinase HipA;
DE            EC=2.7.11.1 {ECO:0000269|PubMed:19150849};
DE   AltName: Full=Toxin HipA;
GN   Name=hipA; OrderedLocusNames=b1507, JW1500;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12;
RX   PubMed=1715862;
RA   Black D.S., Kelly A.J., Mardis M.J., Moyed H.S.;
RT   "Structure and organization of hip, an operon that affects lethality
RT   due to inhibition of peptidoglycan or DNA synthesis.";
RL   J. Bacteriol. 173:5732-5739(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [4]
RP   PROTEIN SEQUENCE OF 134-157, FUNCTION AS A KINASE, ACTIVE SITE,
RP   PHOSPHORYLATION AT SER-150, ANTIBIOTIC TOLERANCE, AND MUTAGENESIS OF
RP   SER-150; ASP-309 AND ASP-332.
RC   STRAIN=K12;
RX   PubMed=17041039; DOI=10.1128/JB.01237-06;
RA   Correia F.F., D'Onofrio A., Rejtar T., Li L., Karger B.L.,
RA   Makarova K., Koonin E.V., Lewis K.;
RT   "Kinase activity of overexpressed HipA is required for growth arrest
RT   and multidrug tolerance in Escherichia coli.";
RL   J. Bacteriol. 188:8360-8367(2006).
RN   [5]
RP   MUTANT HIPA7 ISOLATION, ROLE IN ANTIBIOTIC TOLERANCE, AND ROLE IN
RP   PERSISTENCE.
RC   STRAIN=K12;
RX   PubMed=6348026;
RA   Moyed H.S., Bertrand K.P.;
RT   "hipA, a newly recognized gene of Escherichia coli K-12 that affects
RT   frequency of persistence after inhibition of murein synthesis.";
RL   J. Bacteriol. 155:768-775(1983).
RN   [6]
RP   FUNCTION AS A TOXIN, AND DISRUPTION PHENOTYPE.
RC   STRAIN=K12;
RX   PubMed=8021189;
RA   Black D.S., Irwin B., Moyed H.S.;
RT   "Autoregulation of hip, an operon that affects lethality due to
RT   inhibition of peptidoglycan or DNA synthesis.";
RL   J. Bacteriol. 176:4081-4091(1994).
RN   [7]
RP   FUNCTION AS A TOXIN, FUNCTION IN PERSISTENCE, REQUIREMENT FOR
RP   (P)PPGPP, AND MUTAGENESIS OF GLY-22; ASP-88 AND ASP-291.
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=14622409; DOI=10.1046/j.1365-2958.2003.03779.x;
RA   Korch S.B., Henderson T.A., Hill T.M.;
RT   "Characterization of the hipA7 allele of Escherichia coli and evidence
RT   that high persistence is governed by (p)ppGpp synthesis.";
RL   Mol. Microbiol. 50:1199-1213(2003).
RN   [8]
RP   FUNCTION AS A TOXIN.
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=16707675; DOI=10.1128/JB.01740-05;
RA   Korch S.B., Hill T.M.;
RT   "Ectopic overexpression of wild-type and mutant hipA genes in
RT   Escherichia coli: effects on macromolecular synthesis and persister
RT   formation.";
RL   J. Bacteriol. 188:3826-3836(2006).
RN   [9]
RP   FUNCTION, AND ROLE IN PPGPP RESPONSE.
RX   PubMed=23667235; DOI=10.1128/JB.02210-12;
RA   Bokinsky G., Baidoo E.E., Akella S., Burd H., Weaver D.,
RA   Alonso-Gutierrez J., Garcia-Martin H., Lee T.S., Keasling J.D.;
RT   "HipA-triggered growth arrest and beta-lactam tolerance in Escherichia
RT   coli are mediated by RelA-dependent ppGpp synthesis.";
RL   J. Bacteriol. 195:3173-3182(2013).
RN   [10]
RP   SUBUNIT, AND MODELING OF INTERACTION.
RX   PubMed=24089363; DOI=10.1002/jmr.2300;
RA   Li C., Wang Y., Wang Y., Chen G.;
RT   "Interaction investigations of HipA binding to HipB dimer and HipB
RT   dimer + DNA complex: a molecular dynamics simulation study.";
RL   J. Mol. Recognit. 26:556-567(2013).
RN   [11]
RP   FUNCTION, INTERACTION WITH HIPB, SUBUNIT, AND MASS SPECTROMETRY.
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=24095282; DOI=10.1016/j.molcel.2013.08.045;
RA   Germain E., Castro-Roa D., Zenkin N., Gerdes K.;
RT   "Molecular mechanism of bacterial persistence by HipA.";
RL   Mol. Cell 52:248-254(2013).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) IN COMPLEX WITH HIPB.
RC   STRAIN=K12 / DH5-alpha;
RX   PubMed=19622872; DOI=10.1107/S0907444909018800;
RA   Evdokimov A., Voznesensky I., Fennell K., Anderson M., Smith J.F.,
RA   Fisher D.A.;
RT   "New kinase regulation mechanism found in HipBA: a bacterial
RT   persistence switch.";
RL   Acta Crystallogr. D 65:875-879(2009).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.54 ANGSTROMS) ALONE AND IN COMPLEX WITH
RP   MG-ATP, HIPB AND DNA, FUNCTION AS A KINASE, CATALYTIC ACTIVITY,
RP   ATP-BINDING, DNA-BINDING, SUBSTRATE, AND SUBUNIT.
RX   PubMed=19150849; DOI=10.1126/science.1163806;
RA   Schumacher M.A., Piro K.M., Xu W., Hansen S., Lewis K., Brennan R.G.;
RT   "Molecular mechanisms of HipA-mediated multidrug tolerance and its
RT   neutralization by HipB.";
RL   Science 323:396-401(2009).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.50 ANGSTROMS) PHOSPHORYLATED AND
RP   NON-PHOSPHORYLATED AND IN COMPLEX WITH ATP, ATP-BINDING, ENZYME
RP   REGULATION, AND PHOSPHORYLATION AT SER-150.
RX   PubMed=22999936; DOI=10.1016/j.celrep.2012.08.013;
RA   Schumacher M.A., Min J., Link T.M., Guan Z., Xu W., Ahn Y.H.,
RA   Soderblom E.J., Kurie J.M., Evdokimov A., Moseley M.A., Lewis K.,
RA   Brennan R.G.;
RT   "Role of unusual P loop ejection and autophosphorylation in HipA-
RT   mediated persistence and multidrug tolerance.";
RL   Cell Rep. 2:518-525(2012).
CC   -!- FUNCTION: Toxic component of a toxin-antitoxin (TA) module.
CC       Phosphorylates Glu-tRNA-ligase (GltX, on 'Ser-239') in vivo.
CC       Phosphorylation of GltX prevents it from being charged, leading to
CC       an increase in uncharged tRNA(Glu). This induces amino acid
CC       starvation and the stringent response via RelA/SpoT and increased
CC       ppGpp levels, which inhibits replication, transcription,
CC       translation and cell wall synthesis, reducing growth and leading
CC       to multidrug resistance and persistence. The hipA7 mutation (a
CC       double G22S D291A mutation) leads to increased generation of
CC       persister cells, cells that survive antibiotic treatment probably
CC       by entering into a dormant state. Wild-type cells produce
CC       persisters at a frequency of 10(-6) to 10(-5) whereas mutant hipA7
CC       cells produce persisters at a frequency of 10(-2). Generation of
CC       persister cells requires ppGpp as cells lacking relA or relA/spoT
CC       generate fewer or no persister cells respectively compared to
CC       hipA7. Low level expression of HipA induces dormancy and depending
CC       on the protein level, can be toxic enough to reduce cell growth or
CC       even kill cells. Low levels of wild-type HipA lead to high beta-
CC       lactam antibiotic tolerance of the survivor cells, also dependent
CC       on relA and relA/spoT. The toxic effect of HipA is neutralized by
CC       its cognate antitoxin HipB. With HipB acts as a corepressor for
CC       transcription of the hipBA promoter; binding to DNA induces a 70
CC       degree bend. {ECO:0000269|PubMed:14622409,
CC       ECO:0000269|PubMed:16707675, ECO:0000269|PubMed:17041039,
CC       ECO:0000269|PubMed:19150849, ECO:0000269|PubMed:23667235,
CC       ECO:0000269|PubMed:24095282, ECO:0000269|PubMed:6348026,
CC       ECO:0000269|PubMed:8021189}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000269|PubMed:19150849}.
CC   -!- ENZYME REGULATION: Once phosphorylated no longer has kinase
CC       activity. {ECO:0000269|PubMed:22999936}.
CC   -!- SUBUNIT: Forms a HipA(2)HipB(2) heterotetramer which can interact
CC       with DNA. {ECO:0000269|PubMed:19150849,
CC       ECO:0000269|PubMed:19622872, ECO:0000269|PubMed:22999936,
CC       ECO:0000269|PubMed:24089363, ECO:0000269|PubMed:24095282}.
CC   -!- PTM: Autophosphorylates intermolecularly on Ser-150;
CC       phosphorylated form not seen to bind ATP and no longer has kinase
CC       activity. {ECO:0000269|PubMed:17041039,
CC       ECO:0000269|PubMed:22999936}.
CC   -!- MASS SPECTROMETRY: Mass=49143.80; Method=MALDI; Range=1-440;
CC       Evidence={ECO:0000269|PubMed:24095282};
CC   -!- MASS SPECTROMETRY: Mass=49223.80; Method=MALDI; Range=1-440;
CC       Note=Phosphorylated form.; Evidence={ECO:0000269|PubMed:24095282};
CC   -!- DISRUPTION PHENOTYPE: Cells lacking hipA or the hipBA operon
CC       cannot produce persister cells at a high frequency.
CC       {ECO:0000269|PubMed:8021189}.
CC   -!- SIMILARITY: Belongs to the HipA Ser/Thr kinase family.
CC       {ECO:0000305}.
CC   -!- CAUTION: Has been reported to phosphorylate EF-Tu in vitro (on
CC       'Thr-383') (PubMed:19150849). According to another report, does
CC       not phosphorylate EF-Tu (PubMed:19622872).
CC       {ECO:0000305|PubMed:19150849, ECO:0000305|PubMed:19622872}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M61242; AAA56878.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC74580.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAA15179.2; -; Genomic_DNA.
DR   PIR; F64904; F64904.
DR   RefSeq; NP_416024.1; NC_000913.3.
DR   RefSeq; WP_001125439.1; NZ_CP010445.1.
DR   PDB; 2WIU; X-ray; 2.35 A; A/C=1-440.
DR   PDB; 3DNT; X-ray; 1.66 A; A/B=1-440.
DR   PDB; 3DNU; X-ray; 1.54 A; A=1-440.
DR   PDB; 3DNV; X-ray; 2.68 A; A=1-440.
DR   PDB; 3FBR; X-ray; 3.50 A; A=1-437.
DR   PDB; 3HZI; X-ray; 2.98 A; A=1-440.
DR   PDB; 3TPB; X-ray; 1.88 A; A=1-440.
DR   PDB; 3TPD; X-ray; 1.50 A; A=1-440.
DR   PDB; 3TPE; X-ray; 1.90 A; A=1-440.
DR   PDB; 3TPT; X-ray; 2.25 A; A/B=1-440.
DR   PDB; 3TPV; X-ray; 2.30 A; B=1-440.
DR   PDBsum; 2WIU; -.
DR   PDBsum; 3DNT; -.
DR   PDBsum; 3DNU; -.
DR   PDBsum; 3DNV; -.
DR   PDBsum; 3FBR; -.
DR   PDBsum; 3HZI; -.
DR   PDBsum; 3TPB; -.
DR   PDBsum; 3TPD; -.
DR   PDBsum; 3TPE; -.
DR   PDBsum; 3TPT; -.
DR   PDBsum; 3TPV; -.
DR   ProteinModelPortal; P23874; -.
DR   SMR; P23874; 2-437.
DR   DIP; DIP-9898N; -.
DR   IntAct; P23874; 4.
DR   MINT; MINT-1292260; -.
DR   STRING; 511145.b1507; -.
DR   PaxDb; P23874; -.
DR   PRIDE; P23874; -.
DR   EnsemblBacteria; AAC74580; AAC74580; b1507.
DR   EnsemblBacteria; BAA15179; BAA15179; BAA15179.
DR   GeneID; 946064; -.
DR   KEGG; eco:b1507; -.
DR   PATRIC; 32118308; VBIEscCol129921_1574.
DR   EchoBASE; EB0438; -.
DR   EcoGene; EG10443; hipA.
DR   eggNOG; COG3550; -.
DR   HOGENOM; HOG000188799; -.
DR   InParanoid; P23874; -.
DR   KO; K07154; -.
DR   OMA; KAKMAMA; -.
DR   OrthoDB; EOG6ZSP44; -.
DR   BioCyc; EcoCyc:EG10443-MONOMER; -.
DR   BioCyc; ECOL316407:JW1500-MONOMER; -.
DR   BioCyc; MetaCyc:EG10443-MONOMER; -.
DR   EvolutionaryTrace; P23874; -.
DR   PRO; PR:P23874; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005524; F:ATP binding; IDA:EcoCyc.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:EcoCyc.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:EcoCyc.
DR   GO; GO:0022611; P:dormancy process; IDA:EcoCyc.
DR   GO; GO:0043086; P:negative regulation of catalytic activity; IDA:EcoCyc.
DR   GO; GO:0036289; P:peptidyl-serine autophosphorylation; IDA:EcoCyc.
DR   GO; GO:0046677; P:response to antibiotic; IEA:UniProtKB-KW.
DR   GO; GO:0044010; P:single-species biofilm formation; IMP:EcoCyc.
DR   InterPro; IPR012893; HipA-like_C.
DR   InterPro; IPR017508; HipA_N1.
DR   InterPro; IPR012894; HipA_N2.
DR   Pfam; PF13657; Couple_hipA; 1.
DR   Pfam; PF07804; HipA_C; 1.
DR   Pfam; PF07805; HipA_N; 1.
DR   TIGRFAMs; TIGR03071; couple_hipA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antibiotic resistance; ATP-binding; Complete proteome;
KW   Direct protein sequencing; DNA-binding; Kinase; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Repressor;
KW   Serine/threonine-protein kinase; Toxin; Transferase.
FT   CHAIN         1    440       Serine/threonine-protein kinase HipA.
FT                                /FTId=PRO_0000083988.
FT   NP_BIND     152    157       ATP. {ECO:0000269|PubMed:22999936}.
FT   NP_BIND     234    236       ATP. {ECO:0000269|PubMed:22999936}.
FT   NP_BIND     311    314       ATP. {ECO:0000269|PubMed:22999936}.
FT   NP_BIND     331    332       ATP. {ECO:0000269|PubMed:22999936}.
FT   DNA_BIND    379    382       {ECO:0000269|PubMed:19150849}.
FT   ACT_SITE    309    309       Proton acceptor.
FT                                {ECO:0000305|PubMed:17041039}.
FT   BINDING     181    181       ATP. {ECO:0000269|PubMed:22999936}.
FT   MOD_RES     150    150       Phosphoserine; by autocatalysis.
FT                                {ECO:0000269|PubMed:17041039,
FT                                ECO:0000269|PubMed:22999936}.
FT   MUTAGEN      22     22       G->S: Loss of toxicity, does not confer
FT                                high persistence. Loss of toxicity, high
FT                                persistence and cold sensitivity; in
FT                                hipA7; when associated with A-291.
FT                                {ECO:0000269|PubMed:14622409}.
FT   MUTAGEN      88     88       D->N: Loss of toxicity, still confers
FT                                high persistence.
FT                                {ECO:0000269|PubMed:14622409}.
FT   MUTAGEN     150    150       S->A: No phosphorylation; cells grow
FT                                normally. {ECO:0000269|PubMed:17041039}.
FT   MUTAGEN     291    291       D->A: Retains toxicity and high
FT                                persistence but not cold-sensitive. Loss
FT                                of toxicity, high persistence and cold
FT                                sensitivity; in hipA7; when associated
FT                                with S-22. {ECO:0000269|PubMed:14622409}.
FT   MUTAGEN     309    309       D->Q: Loss of autophosphorylation; cells
FT                                grow normally; protein can accumulate to
FT                                high levels in E.coli.
FT                                {ECO:0000269|PubMed:17041039}.
FT   MUTAGEN     332    332       D->Q: Loss of autophosphorylation; cells
FT                                grow normally.
FT                                {ECO:0000269|PubMed:17041039}.
FT   CONFLICT     40     40       P -> Q (in Ref. 1; AAA56878).
FT                                {ECO:0000305}.
FT   CONFLICT    214    215       GL -> WV (in Ref. 1; AAA56878).
FT                                {ECO:0000305}.
FT   CONFLICT    274    274       G -> R (in Ref. 1; AAA56878).
FT                                {ECO:0000305}.
FT   STRAND        3      8       {ECO:0000244|PDB:3TPD}.
FT   STRAND       11     18       {ECO:0000244|PDB:3TPD}.
FT   STRAND       24     28       {ECO:0000244|PDB:3TPD}.
FT   HELIX        30     34       {ECO:0000244|PDB:3TPD}.
FT   STRAND       35     37       {ECO:0000244|PDB:3DNV}.
FT   STRAND       49     52       {ECO:0000244|PDB:3DNT}.
FT   HELIX        55     62       {ECO:0000244|PDB:3TPD}.
FT   STRAND       65     67       {ECO:0000244|PDB:2WIU}.
FT   HELIX        69     79       {ECO:0000244|PDB:3TPD}.
FT   STRAND       82     85       {ECO:0000244|PDB:3TPV}.
FT   HELIX        86     93       {ECO:0000244|PDB:3TPD}.
FT   STRAND       98    100       {ECO:0000244|PDB:3DNT}.
FT   STRAND      101    104       {ECO:0000244|PDB:3TPD}.
FT   STRAND      114    116       {ECO:0000244|PDB:3FBR}.
FT   STRAND      117    119       {ECO:0000244|PDB:3TPD}.
FT   HELIX       122    130       {ECO:0000244|PDB:3TPD}.
FT   TURN        131    133       {ECO:0000244|PDB:3DNU}.
FT   HELIX       137    139       {ECO:0000244|PDB:3DNT}.
FT   STRAND      149    152       {ECO:0000244|PDB:3TPE}.
FT   STRAND      153    155       {ECO:0000244|PDB:3DNU}.
FT   STRAND      158    163       {ECO:0000244|PDB:3TPD}.
FT   STRAND      166    170       {ECO:0000244|PDB:3TPD}.
FT   STRAND      178    181       {ECO:0000244|PDB:3TPD}.
FT   STRAND      185    188       {ECO:0000244|PDB:3TPE}.
FT   STRAND      189    191       {ECO:0000244|PDB:3FBR}.
FT   STRAND      193    196       {ECO:0000244|PDB:3TPE}.
FT   HELIX       199    212       {ECO:0000244|PDB:3TPD}.
FT   STRAND      220    225       {ECO:0000244|PDB:3TPD}.
FT   STRAND      228    234       {ECO:0000244|PDB:3TPD}.
FT   STRAND      236    240       {ECO:0000244|PDB:3TPD}.
FT   STRAND      247    249       {ECO:0000244|PDB:3TPD}.
FT   STRAND      252    254       {ECO:0000244|PDB:3TPD}.
FT   HELIX       255    258       {ECO:0000244|PDB:3TPD}.
FT   HELIX       263    265       {ECO:0000244|PDB:3TPD}.
FT   HELIX       268    270       {ECO:0000244|PDB:3TPD}.
FT   HELIX       275    282       {ECO:0000244|PDB:3TPD}.
FT   HELIX       288    304       {ECO:0000244|PDB:3TPD}.
FT   HELIX       312    314       {ECO:0000244|PDB:3TPD}.
FT   STRAND      316    319       {ECO:0000244|PDB:3TPD}.
FT   HELIX       321    323       {ECO:0000244|PDB:3TPD}.
FT   STRAND      325    327       {ECO:0000244|PDB:3TPD}.
FT   HELIX       337    339       {ECO:0000244|PDB:3TPD}.
FT   STRAND      342    344       {ECO:0000244|PDB:3TPD}.
FT   HELIX       347    349       {ECO:0000244|PDB:3TPD}.
FT   STRAND      351    358       {ECO:0000244|PDB:3TPD}.
FT   STRAND      361    365       {ECO:0000244|PDB:3TPD}.
FT   HELIX       366    368       {ECO:0000244|PDB:3TPD}.
FT   HELIX       371    381       {ECO:0000244|PDB:3TPD}.
FT   HELIX       385    407       {ECO:0000244|PDB:3TPD}.
FT   STRAND      412    414       {ECO:0000244|PDB:3FBR}.
FT   HELIX       416    434       {ECO:0000244|PDB:3TPD}.
SQ   SEQUENCE   440 AA;  49276 MW;  378771C4CAB55319 CRC64;
     MPKLVTWMNN QRVGELTKLA NGAHTFKYAP EWLASRYARP LSLSLPLQRG NITSDAVFNF
     FDNLLPDSPI VRDRIVKRYH AKSRQPFDLL SEIGRDSVGA VTLIPEDETV THPIMAWEKL
     TEARLEEVLT AYKADIPLGM IREENDFRIS VAGAQEKTAL LRIGNDWCIP KGITPTTHII
     KLPIGEIRQP NATLDLSQSV DNEYYCLLLA KELGLNVPDA EIIKAGNVRA LAVERFDRRW
     NAERTVLLRL PQEDMCQTFG LPSSVKYESD GGPGIARIMA FLMGSSEALK DRYDFMKFQV
     FQWLIGATDG HAKNFSVFIQ AGGSYRLTPF YDIISAFPVL GGTGIHISDL KLAMGLNASK
     GKKTAIDKIY PRHFLATAKV LRFPEVQMHE ILSDFARMIP AALDNVKTSL PTDFPENVVT
     AVESNVLRLH GRLSREYGSK
//
